Form 4: Nuvalent Director Matthew Shair Sells Shares Under 10b5-1 Trading Plan

Director Matthew Shair of Nuvalent, Inc. executed multiple sales of Class A Common Stock on April 8, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On April 8, 2024, Matthew Shair, a director of Nuvalent, Inc., sold shares of Class A Common Stock.
• The sales were executed under a Rule 10b5-1 trading plan adopted on December 21, 2023.
• A total of 37,500 shares were sold in multiple transactions at varying prices.
• The weighted average sale prices ranged from $67.89 to $69.64.
• Following the reported transactions, Shair directly owns 1,612,198 shares of Class A Common Stock.
• Additionally, 238,522 shares are held indirectly through the Matthew D. Shair 2021 Irrevocable Family Trust, over which Shair has voting and dispositive power.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports the execution of pre-planned stock sales under a 10b5-1 trading plan, which is a common practice. There is no indication of positive or negative implications for the company's performance.

Industry Context

Sales by insiders are a common occurrence, and the use of a 10b5-1 plan suggests the sales were pre-planned and not based on current, non-public information. Investors often monitor insider transactions for signals about a company's prospects, but pre-planned sales are generally viewed as less informative.

Stakeholder Impact

• The sale of shares by a director could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates